The Department of Pediatrics and Human Development Division of Pediatric Hematology/Oncology operates clinics from Sparrow Professional Building Suite #145, across from Sparrow Hospital in downtown Lansing. We also provide inpatient services at the Sparrow Regional Children’s Center, and operate an outreach clinic from Marquette General Hospital serving the Upper Peninsula approximately once per month.
Clinical Trials
Local members of the Children’s Oncology Group (COG), a cooperative group including pediatric oncologists from the United States and several foreign countries, conduct clinical trials for children and adolescents at Michigan State University and Sparrow Health System. Most clinical trials are open to individuals from birth to 21 years of age who meet disease-and-study-specific eligibility criteria. The list of COG clinical trials changes frequently, and patients or caregivers interested in participating should contact our pediatric oncologists.
Sickle Cell Disease
Dr. Ajovi Scott-Emuakpor oversees our sickle cell disease program. Offering a full spectrum of inpatient and outpatient services, Dr. Scott sees sickle cell patients at Sparrow Professional Building #145 in downtown Lansing.
Bleeding and Clotting
The Michigan State University Center for Bleeding and Clotting Disorders was established more than 25 years ago to serve newborns, children, adolescents, and adults – both male and female – suffering from hematological conditions. Located at X, we hold one clinic per month for pediatric patients, and one clinic per month for adult patients.
Disorders we treat includes:
- Hemophilia A and B
- Von Willebrand disease
- Rare bleeding and platelet disorders
- Venous and arterial thrombosis
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Stroke